BARTOLI, FRANCESCA
BARTOLI, FRANCESCA
Medicina Sperimentale e Clinica
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR)
2022 Melis, M. R.; El Aoufy, K.; Bruni, C.; Bartoli, F.; Fiori, G.; Guiducci, S.; Bellando Randone, S.; Bambi, S.; Rasero, L.; Matucci-Cerinic, M.
Calcinosis in systemic sclerosis: subsets, distribution and complications
2016 Bartoli, Francesca; Fiori, Ginevra; Braschi, Francesca; Amanzi, Laura; Bruni, Cosimo; Blagojevic, Jelena; Bellando-Randone, Silvia; Cometi, Laura; de Souza Mueller, Carolina; Guiducci, Serena; Rasero, Laura; Epifani, Francesco; Furst, Daniel E; Matucci-Cerinic, Marco
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis.
2007 KALOUDI O; BASTA G; PERFETTO F; BARTOLI F; DEL ROSSO A; MINIATI I; CONFORTI ML; GENERINI S; GUIDUCCI S; ABBATE R; PIGNONE A; CASTELLANI S; LIVI R; DE CATERINA R; MATUCCI CERINIC M
Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA).
2013 Bandinelli F;Prignano F;Bonciani D;Pallanti S;Lotti T;Salaffi F;Bartoli F;Candelieri A;Giovannini L;Maddali Bongi S;Matucci-Cerinic M
Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis.
2007 Sherer Y;Cerinic MM;Bartoli F;Blagojevic J;Conforti ML;Gilburd B;Ehrenfeld M;Shoenfeld Y
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS
2020 M. Passalacqua , C. Foggi, N. Mauro, L. Tofani, S. Guiducci, C. Bruni, G. Lepri, J. Blagojevi, K. El Aoufy, G. Fiori, F. Bartoli, S. Maddali Bongi, M. Mitola, M. Gizduloch, M. Matucci-Cerinic, S. Bellando Randone
FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists
2009 Guiducci, S.; Nacci, F.; Bartoli, F.; Romano, E.; Ceccarelli, C.; Fiori, G.; Sacu, O.; Maddali Bongi, S.; Matucci Cerinic, M.
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA
2021 Melis MR, El Aoufi K, Bartoli F, G. Fiori, C. Bruni, S. Bellando Randone, S. Guiducci, M. Matucci Cerinic, L. Rasero
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2
2021 K. El Aoufy, MR. Melis, S. Bellando Randone, J. Blagojevic, F. Bartoli, G. Fiori, F. Nacci, ML. Conforti, L. Cometi, C. Bruni, A. Moggi Pignone, L. Rasero, S. Guiducci, M. Matucci Cerinic
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience
2021 Agostini E.; De Luca G.; Bruni C.; Bartoli F.; Tofani L.; Campochiaro C.; Pacini G.; Moggi-Pignone A.; Guiducci S.; Bellando-Randone S.; Shoenfeld Y.; Dagna L.; Matucci-Cerinic M.
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study.
2013 Elhai M;Meunier M;Matucci-Cerinic M;Maurer B;Riemekasten G;Leturcq T;Pellerito R;Von Mühlen CA;Vacca A;Airo P;Bartoli F;Fiori G;Bokarewa M;Riccieri V;Becker M;Avouac J;Müller-Ladner U;Distler O;Allanore Y;EUSTAR (EULAR Scleroderma Trials and Research group)
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study).
2010 Scarpato S; Antivalle M; Favalli EG; Nacci F; Frigelli S; Bartoli F; Bazzichi L; Minisola G; Matucci Cerinic M; RIVIERA co-authors
Persistence of remission after lengthening of golimumab in inflammatory joint diseases
2023 Damiani, Arianna; Bartoli, Francesca; Pacini, Giovanni; Carboni, Davide; Bellando Randone, Silvia; Fiori, Ginevra; Matucci-Cerinic, Marco; Guiducci, Serena
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides
2012 Peruzzi, F.; Bartalesi, F.; Attala, L.; Cavallo, A.; Fiori, G.; Maddali-Bongi, S.; Bruni, C.; Nacci, F.; Bartoli, F.; Cappelli, S.; Denaro, V.; Bartoloni, A.; Matucci-Cerinic, M.
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus
2021 Ingegnoli, Francesca; Herrick, Ariane L; Schioppo, Tommaso; Bartoli, Francesca; Ughi, Nicola; Pauling, John D; Sulli, Alberto; Cutolo, Maurizio; Smith, Vanessa
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis
2021 Bruni, Cosimo; Gentileschi, Stefano; Pacini, Giovanni; Bardelli, Marco; Tofani, Lorenzo; Bartoli, Francesca; Baldi, Caterina; Cometi, Laura; Fiori, Ginevra; Nacci, Francesca; Cantarini, Luca; Guiducci, Serena; Moggi-Pignone, Alberto; Frediani, Bruno; Matucci-Cerinic, Marco
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES
2021 El Aoufy, K; Melis, MR; Randone, SB; Blagojevic, J; Bartoli, F; Fiori, G; Nacci, F; Conforti, ML; Cometi, L; Bruni, C; Pignone, AM; Rasero, L; Guiducci, S; Matucci-Cerinic, M
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn).
2005 Bandinelli F; Bartoli F; Perfetto E; Del Rosso A; Moggi Pignone A; Guiducci S; Cinelli M; Fatini C; Generini S; Gabrielli A; Giacomelli R; Maddali Bongi S; Abbate R; Del Rosso M; Matucci Cerinic M.
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life
2022 El Aoufy K.; Melis M.R.; Bellando Randone S.; Blagojevic J.; Bartoli F.; Fiori G.; Nacci F.; Conforti M.L.; Cometi L.; Bruni C.; Orlandi M.; Moggi-Pignone A.; Rasero L.; Guiducci S.; Matucci-Cerinic M.
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases
2024 Coccia C.; Bonomi F.; Lo Cricchio A.; Russo E.; Peretti S.; Bandini G.; Lepri G.; Bartoli F.; Moggi-Pignone A.; Guiducci S.; Del Galdo F.; Furst D.E.; Matucci Cerinic M.; Bellando-Randone S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) | 2022 | Melis, M. R.; El Aoufy, K.; Bruni, C.; Bartoli, F.; Fiori, G.; Guiducci, S.; Bellando Randone, S.; Bambi, S.; Rasero, L.; Matucci-Cerinic, M. | |
| Calcinosis in systemic sclerosis: subsets, distribution and complications | 2016 | Bartoli, Francesca; Fiori, Ginevra; Braschi, Francesca; Amanzi, Laura; Bruni, Cosimo; Blagojevic, Jelena; Bellando-Randone, Silvia; Cometi, Laura; de Souza Mueller, Carolina; Guiducci, Serena; Rasero, Laura; Epifani, Francesco; Furst, Daniel E; Matucci-Cerinic, Marco | |
| Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. | 2007 | KALOUDI O; BASTA G; PERFETTO F; BARTOLI F; DEL ROSSO A; MINIATI I; CONFORTI ML; GENERINI S; GUIDUCCI S; ABBATE R; PIGNONE A; CASTELLANI S; LIVI R; DE CATERINA R; MATUCCI CERINIC M | |
| Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). | 2013 | Bandinelli F;Prignano F;Bonciani D;Pallanti S;Lotti T;Salaffi F;Bartoli F;Candelieri A;Giovannini L;Maddali Bongi S;Matucci-Cerinic M | |
| Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. | 2007 | Sherer Y;Cerinic MM;Bartoli F;Blagojevic J;Conforti ML;Gilburd B;Ehrenfeld M;Shoenfeld Y | |
| EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS | 2020 | M. Passalacqua , C. Foggi, N. Mauro, L. Tofani, S. Guiducci, C. Bruni, G. Lepri, J. Blagojevi, K. El Aoufy, G. Fiori, F. Bartoli, S. Maddali Bongi, M. Mitola, M. Gizduloch, M. Matucci-Cerinic, S. Bellando Randone | |
| FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists | 2009 | Guiducci, S.; Nacci, F.; Bartoli, F.; Romano, E.; Ceccarelli, C.; Fiori, G.; Sacu, O.; Maddali Bongi, S.; Matucci Cerinic, M. | |
| GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA | 2021 | Melis MR, El Aoufi K, Bartoli F, G. Fiori, C. Bruni, S. Bellando Randone, S. Guiducci, M. Matucci Cerinic, L. Rasero | |
| IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 | 2021 | K. El Aoufy, MR. Melis, S. Bellando Randone, J. Blagojevic, F. Bartoli, G. Fiori, F. Nacci, ML. Conforti, L. Cometi, C. Bruni, A. Moggi Pignone, L. Rasero, S. Guiducci, M. Matucci Cerinic | |
| Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience | 2021 | Agostini E.; De Luca G.; Bruni C.; Bartoli F.; Tofani L.; Campochiaro C.; Pacini G.; Moggi-Pignone A.; Guiducci S.; Bellando-Randone S.; Shoenfeld Y.; Dagna L.; Matucci-Cerinic M. | |
| Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study. | 2013 | Elhai M;Meunier M;Matucci-Cerinic M;Maurer B;Riemekasten G;Leturcq T;Pellerito R;Von Mühlen CA;Vacca A;Airo P;Bartoli F;Fiori G;Bokarewa M;Riccieri V;Becker M;Avouac J;Müller-Ladner U;Distler O;Allanore Y;EUSTAR (EULAR Scleroderma Trials and Research group) | |
| Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). | 2010 | Scarpato S; Antivalle M; Favalli EG; Nacci F; Frigelli S; Bartoli F; Bazzichi L; Minisola G; Matucci Cerinic M; RIVIERA co-authors | |
| Persistence of remission after lengthening of golimumab in inflammatory joint diseases | 2023 | Damiani, Arianna; Bartoli, Francesca; Pacini, Giovanni; Carboni, Davide; Bellando Randone, Silvia; Fiori, Ginevra; Matucci-Cerinic, Marco; Guiducci, Serena | |
| Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides | 2012 | Peruzzi, F.; Bartalesi, F.; Attala, L.; Cavallo, A.; Fiori, G.; Maddali-Bongi, S.; Bruni, C.; Nacci, F.; Bartoli, F.; Cappelli, S.; Denaro, V.; Bartoloni, A.; Matucci-Cerinic, M. | |
| Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus | 2021 | Ingegnoli, Francesca; Herrick, Ariane L; Schioppo, Tommaso; Bartoli, Francesca; Ughi, Nicola; Pauling, John D; Sulli, Alberto; Cutolo, Maurizio; Smith, Vanessa | |
| Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis | 2021 | Bruni, Cosimo; Gentileschi, Stefano; Pacini, Giovanni; Bardelli, Marco; Tofani, Lorenzo; Bartoli, Francesca; Baldi, Caterina; Cometi, Laura; Fiori, Ginevra; Nacci, Francesca; Cantarini, Luca; Guiducci, Serena; Moggi-Pignone, Alberto; Frediani, Bruno; Matucci-Cerinic, Marco | |
| THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES | 2021 | El Aoufy, K; Melis, MR; Randone, SB; Blagojevic, J; Bartoli, F; Fiori, G; Nacci, F; Conforti, ML; Cometi, L; Bruni, C; Pignone, AM; Rasero, L; Guiducci, S; Matucci-Cerinic, M | |
| The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). | 2005 | Bandinelli F; Bartoli F; Perfetto E; Del Rosso A; Moggi Pignone A; Guiducci S; Cinelli M; Fatini C; Generini S; Gabrielli A; Giacomelli R; Maddali Bongi S; Abbate R; Del Rosso M; Matucci Cerinic M. | |
| The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life | 2022 | El Aoufy K.; Melis M.R.; Bellando Randone S.; Blagojevic J.; Bartoli F.; Fiori G.; Nacci F.; Conforti M.L.; Cometi L.; Bruni C.; Orlandi M.; Moggi-Pignone A.; Rasero L.; Guiducci S.; Matucci-Cerinic M. | |
| The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases | 2024 | Coccia C.; Bonomi F.; Lo Cricchio A.; Russo E.; Peretti S.; Bandini G.; Lepri G.; Bartoli F.; Moggi-Pignone A.; Guiducci S.; Del Galdo F.; Furst D.E.; Matucci Cerinic M.; Bellando-Randone S. |